α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation-Reference-Cited by-同舟云学术

α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation

Published:2021-10 Issue: Volume:116 Page:39-48
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Nakamura Harumi^ORCID,Kukita Yoji^ORCID,Kunimasa Kei,Kittaka Nobuyoshi,Kusama Hiroki,Nakayama Takahiro,Tamaki Yasuhiro^ORCID,Sugiura Ryoko,Yasuda Hidemitsu,Hashimoto Masanori^ORCID,Yamamoto Takashi,Imamura Fumio,Nakatsuka Sin-ichi^ORCID

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference20 articles.

1. Apocrine carcinoma;Brogi,2014

2. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation;Niemeter;Mod Pathol,2010

3. Mitochondrial and peroxisomal targeting of 2-methyl-CoA racemase in humans;Amery;J Lipid Res,2000

4. α-Methylacyl-CoA racemase – an ‘obscure’ metabolic enzyme takes centre stage;Lloyd;FEBS J,2008

5. Identification of molecular apocrine breast tumours by microarray analysis;Farmer;Oncogene,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in cancer energy metabolism under dietary restriction: a mini review;Medical Oncology;2024-07-26

2. Apocrine lesions of breast and invasive carcinoma with apocrine differentiation: a brief review;Surgical and Experimental Pathology;2023-11-10

3. Apocrine carcinoma of the breast: Review;Forum of Clinical Oncology;2023-09-15

4. AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers;Clinical Breast Cancer;2023-02

5. Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation;Human Pathology;2022-11